Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Friday 18 September 2015 11:41 am

British scientists are trying to genetically alter human embryos for the first time

By: Sarah Spickernell

Add as a preferred source on Google

The UK's science community has steered well clear of the controversial practice of genetically modifying human embryos. But now, scientists at London's Francis Crick Institute are trying to get permission to do just that, marking what could be a huge turning point in British science.
 
Using a novel gene-correction technique called Crispr/Cas9, they want to change the genetic make-up of spare embryos donated by IVF patients to study the early stages of human development, which could ultimately lead to the creation of new treatments for diseases.
 
If they are granted permission by the Human Fertilisation and Embryology Authority, engineered embryos could be created in the UK within months. 
 
Read more: Antibiotic resistance: Genome editor could provide the cure
 
Kathy Niakan, one of the researchers involved in the application, told The Guardian that the procedure would be used to determine which genes are involved in the first few days of human fertilisation, and therefore to find out why some women lose their babies early on in pregnancy. 
 
The knowledge we acquire will be very important for understanding how a healthy human embryo develops, and this will inform our understanding of the causes of miscarriage. It is not a slippery slope [towards designer babies] because the UK has very tight regulation in this area. 
 
The application for the license follows a breakthrough made by scientists in the University of Guangzhou, China last April, when Crispr was used on leftover IVF embryos to modify the gene that causes a fatal blood disorder called  beta-thalassaemia.
 
Read more: UK biotech company could transform treatment of genetic diseases with RNA technique

The prospect of genetically engineering embryos has met huge criticism, although UK laws are currently in place to prevent these embryos being implanted in women, and the team at the Francis Crick Institute have been clear that they will only use the method for scientific research. 

There are also concerns that this kind of genetic manipulation could lead to unforeseen consequences in a human's body if an altered embryo is allowed to grow, and that harmful changes could pass on down through generations.
 
So deep are these concerns that the US government has completely banned government-funded research in America. In the UK, this kind of research is technically legal, but only for a maximum of two weeks per embryo.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • IFF to Webcast Fireside Chat at Barclays Global Consumer Conference on Sept. 10

    Business Wire
  • Brits fear AI is slipping out of human control after ‘rogue’ systems escape tests

    Tech
    Dario Amodei, CEO of Anthropic, speaking at a tech conference podium, wearing a suit and addressing the audience.
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
  • Claude to watermark AI ‘slop’ – including edited human writing

    Tech
    Smartphone displaying the Claude by Anthropic AI assistant app, showing the app icon and interface.
  • Plaud Unveils Plaud One Explorer Edition, the Wearable AI Earbuds Built for the Agent Era

    Business Wire
  • TfL greenlights Wayve’s autonomous vehicles in the City

    Tech
    Wayve autonomous vehicle navigating a busy London street with iconic cityscape in the background
  • Astrazeneca and Jaguar Land Rover given power to endorse talented migrants for visas

    Politics
    Jonathan Reynolds addressing the SMMT's annual International Automotive Summit (image courtesy of SMMT)
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook